Loomis Sayles & CO L P Ascendis Pharma A/S Transaction History

Loomis Sayles & CO L P

$76.2 Billion
Q3 2024

A detailed history of Loomis Sayles & CO L P transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Loomis Sayles & CO L P holds 184,623 shares of ASND stock, worth $25.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

184,623

Previous 121,594 51.84%

Holding current value

$25.2 Million

Previous $16.6 Million 66.23%

% of portfolio

0.04%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$113.0 - $153.43 $7.12 Million - $9.67 Million	63,029 Added 51.84%	184,623 $27.6 Million
Q2 2024 Aug 13, 2024	BUY	$121.07 - $153.67 $14.7 Million - $18.7 Million	121,594 New	121,594 $16.6 Million
Q3 2021 Nov 12, 2021	SELL	$112.67 - $176.92 $20.2 Million - $31.7 Million	-179,446 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$121.62 - $145.29 $834,556 - $996,979	6,862 Added 3.98%	179,446 $23.6 Million
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $1.87 Million - $2.59 Million	14,948 Added 9.48%	172,584 $22.2 Million
Q4 2020 Feb 12, 2021	BUY	$151.2 - $182.76 $4.93 Million - $5.96 Million	32,626 Added 26.1%	157,636 $26.3 Million
Q3 2020 Nov 12, 2020	SELL	$134.29 - $154.32 $185,320 - $212,961	-1,380 Reduced 1.09%	125,010 $19.3 Million
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $1.09 Million - $1.53 Million	9,795 Added 8.4%	126,390 $18.7 Million
Q1 2020 May 15, 2020	SELL	$97.01 - $145.11 $124,754 - $186,611	-1,286 Reduced 1.09%	116,595 $13.1 Million
Q4 2019 Feb 14, 2020	SELL	$91.45 - $139.12 $821,769 - $1.25 Million	-8,986 Reduced 7.08%	117,881 $16.4 Million
Q3 2019 Nov 13, 2019	BUY	$95.8 - $118.9 $2.46 Million - $3.05 Million	25,664 Added 25.36%	126,867 $12.2 Million
Q2 2019 Aug 14, 2019	SELL	$107.11 - $132.09 $657,762 - $811,164	-6,141 Reduced 5.72%	101,203 $11.7 Million
Q1 2019 May 15, 2019	SELL	$62.15 - $129.99 $22,311 - $46,666	-359 Reduced 0.33%	107,344 $12.6 Million
Q4 2018 Feb 14, 2019	BUY	$55.16 - $69.67 $1.08 Million - $1.37 Million	19,648 Added 22.31%	107,703 $6.75 Million
Q3 2018 Nov 13, 2018	BUY	$63.77 - $76.28 $5.62 Million - $6.72 Million	88,055 New	88,055 $6.24 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Ascendis Pharma A/S Transaction History